Revenue
2021
2022
2023
2024
2025
Lucid Diagnostics Inc. (LUCD)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2021
2022
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $4.7M | $4.3M | $2.4M | $377,000 | $500,000 | — |
| Gross profit | — | — | — | $377,000 | $500,000 | — |
| Research & development | $5.7M | $6.0M | $7.3M | $11.3M | $9.3M | $5.4M |
| Operating expenses | — | $50.4M | $50.9M | $56.6M | $27.9M | $8.3M |
| Operating income | −$49.6M | −$46.1M | −$48.5M | −$56.3M | −$27.4M | −$8.3M |
| EBITDAderived | −$48.8M | −$44.9M | −$46.0M | −$54.3M | −$27.4M | — |
| Net income | −$58.0M | −$45.5M | −$52.7M | −$56.2M | −$28.1M | −$8.3M |
| Basic EPSper diluted share | -$0.69 | -$1.05 | -$1.26 | -$1.55 | -$1.51 | -$0.59 |
| Diluted EPSper diluted share | — | -$1.05 | -$1.26 | -$1.55 | -$1.51 | -$0.59 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 20, 2026Form 4 | Matheis DennisDirector | BuyCommon Stock | 245.0K | $1.00 | $245.0K | 1.03M |
| Aug 20, 2025Form 4 | Matheis DennisDirector | BuyCommon Stock | 100.0K | $1.02 | $102.0K | 665.4K |
| May 22, 2025Form 4/A | Matheis DennisDirector | BuyCommon Stock | 33.2K | $1.32 | $43.8K | 565.4K |
| May 22, 2025Form 4 | Matheis DennisDirector | BuyCommon Stock | 33.2K | $1.32 | $43.8K | 350.0K |
| May 21, 2025Form 4/A | Matheis DennisDirector | BuyCommon Stock | 129.7K | $1.32 | $171.2K | 532.2K |